Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Contraceptive agents

Pharmacists urged to explain potential effect of body weight on emergency contraception

Levonelle emergency contraception pill (pictured) is one of the pills thought to be affected by weight

Source: Ian Miles-Flashpoint Pictures / Alamy Stock Photo

The FSRH says pharmacists and doctors should warn women that the emergency contraceptive pill may be ineffective in those with higher body weight.

The Faculty of Sexual and Reproductive Healthcare (FSRH) has urged pharmacists and doctors to explain to patients that the emergency contraceptive pill can be ineffective in women weighing 11 stone or more, or with a body-mass index of 26 or above. 

The appeal comes following new FSRH guidance on emergency contraception, published in March 2017, which aims to summarise the available evidence on emergency contraception for healthcare professionals.

In 2014, the European Medicines Agency, which evaluates medicinal products for use in Europe, concluded that there is limited evidence showing oral emergency contraception to be less effective in women with higher body weight. But the FSRH’s guidance states that “women should be informed that it is possible that it could reduce the effectiveness”.

Jane Dickson, vice president of the FSRH, highlighted that 15 stone was the “danger point” for some women, but 11 stone has been suggested as the weight that may start to pose risk. Consequently, the FSRH guideline development group recommends that if a copper intrauterine device is not indicated, women can be offered ulipristal acetate (EllaOne), but if this is not suitable, a double dose of levonorgestrel (3mg) can be used.

“The coil’s effectiveness is not affected by a woman’s weight as it works differently to prevent fertilisation – it’s toxic to sperm and eggs and works locally,” says Dickson.

Gedeon Richter Ltd, the manufacturers of Levonelle (levonorgestrel), one of the pills thought to be affected by weight, said: “We are aware of some uncertainties regarding the efficacy of levonorgestrel emergency contraceptive tablets in women with a BMI greater than 30, but as a result of the limited number of patients involved in these studies, the relevance of these data are questionable.

“As a company that is responsible for women’s health, we are considering updating the summary of product characteristics regarding the effect of increased weight/BMI on the effectiveness of oral levonorgestrel containing emergency contraceptives. The available evidence and data is being reviewed and analysed and the company will make a well-based and thorough decision on this after the evaluation procedure.”

  • On 10 April 2017, this story was amended to include further guidance on copper intrauterine device contraindication.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2017.20202571

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • Levonelle emergency contraception pill (pictured) is one of the pills thought to be affected by weight

Jobs you might like

See more jobs

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.